Statistics for A Phase II Trial of Adjuvant Durvalumab Following Trimodality Therapy for Locally Advanced Esophageal and Gastroesophageal Junction Adenocarcinoma: A Big Ten Cancer Research Consortium Study
Total visits
| views | |
|---|---|
| A Phase II Trial of Adjuvant Durvalumab Following Trimodality Therapy for Locally Advanced Esophageal and Gastroesophageal Junction Adenocarcinoma: A Big Ten Cancer Research Consortium Study | 6 |
Total visits per month
| views | |
|---|---|
| September 2024 | 0 |
| October 2024 | 0 |
| November 2024 | 0 |
| December 2024 | 0 |
| January 2025 | 0 |
| February 2025 | 0 |
| March 2025 | 0 |
File Visits
| views | |
|---|---|
| java.util.UUID:fc51fc11-e97b-4c54-91b5-9d15a1591827 | 51 |
| java.util.UUID:7afa97cd-7102-4a5d-95bb-42e12ff305ce | 11 |
| java.util.UUID:cfc7a423-87d9-477b-bf23-0e43cf6df44e | 10 |
| Mamdani2021PhaseII-CCBY.pdf | 5 |
Top country views
| views | |
|---|---|
| United States | 5 |
| India | 1 |
Top city views
| views | |
|---|---|
| Bloomington | 2 |
| Indianapolis | 2 |
| Trenton | 1 |